Review: taking Allegra and Zantac together


Summary

Drug interactions are reported among people who take Allegra and Zantac together. This review analyzes the effectiveness and drug interactions between Allegra and Zantac. It is created by eHealthMe based on reports of 1,501 people who take the same drugs from FDA and social media, and is updated regularly.

You are not alone

Join a support group for people who take Allegra and Zantac >>>

Personalized health information

On eHealthMe you can find out what patients like me (same gender, age) reported their drugs and conditions on FDA and social media since 1977. Our tools are free and anonymous. 86 million people have used us. 300+ peer-reviewed medical journals have referenced our original studies. Start now >>>


Allegra

Allegra has active ingredients of fexofenadine hydrochloride. It is often used in hypersensitivity. (latest outcomes from Allegra 27,014 users)

Zantac

Zantac has active ingredients of ranitidine hydrochloride. It is often used in indigestion. (latest outcomes from Zantac 39,441 users)

On Aug, 26, 2016

1,501 people who take Allegra, Zantac are studied.


Number of reports submitted per year:

Allegra and Zantac drug interactions.

Drug effectiveness over time:

Allegra:
  • < 1 month: 14.0% - (1 of 7 people)
  • 1 - 6 months: 0.0% - (0 of 11 people)
  • 6 - 12 months: 0.0% - (0 of 4 people)
  • 1 - 2 years: 50.0% - (2 of 4 people)
  • 2 - 5 years: 63.0% - (7 of 11 people)
  • 5 - 10 years: 25.0% - (1 of 4 people)
  • 10+ years: 50.0% - (1 of 2 people)
  • not specified: 0.0% - (0 of 0 people)
Zantac:
  • < 1 month: 20.0% - (2 of 10 people)
  • 1 - 6 months: 25.0% - (3 of 12 people)
  • 6 - 12 months: 14.0% - (1 of 7 people)
  • 1 - 2 years: 50.0% - (3 of 6 people)
  • 2 - 5 years: 33.0% - (2 of 6 people)
  • 5 - 10 years: 0.0% - (0 of 2 people)
  • 10+ years: 33.0% - (1 of 3 people)
  • not specified: 0.0% - (0 of 0 people)

Drug effectiveness by gender:

Allegra:
  • female: 29.0% - (10 of 34 people)
  • male: 22.0% - (2 of 9 people)
Zantac:
  • female: 25.0% - (9 of 36 people)
  • male: 30.0% - (3 of 10 people)

Drug effectiveness by age:

Allegra:
  • 0-1: 0.0% - (0 of 0 people)
  • 2-9: 0.0% - (0 of 1 people)
  • 10-19: 50.0% - (1 of 2 people)
  • 20-29: 20.0% - (1 of 5 people)
  • 30-39: 37.0% - (3 of 8 people)
  • 40-49: 16.0% - (2 of 12 people)
  • 50-59: 33.0% - (3 of 9 people)
  • 60+: 33.0% - (2 of 6 people)
Zantac:
  • 0-1: 0.0% - (0 of 1 people)
  • 2-9: 0.0% - (0 of 1 people)
  • 10-19: 50.0% - (1 of 2 people)
  • 20-29: 0.0% - (0 of 5 people)
  • 30-39: 22.0% - (2 of 9 people)
  • 40-49: 30.0% - (4 of 13 people)
  • 50-59: 33.0% - (3 of 9 people)
  • 60+: 33.0% - (2 of 6 people)

Most common drug interactions over time *:

< 1 month:
  • abdominal pain
  • hypokalaemia
  • liver carcinoma ruptured
  • aspartate aminotransferase increased
  • platelet count decreased
  • chest tightness
  • diaphoresis
  • febrile neutropenia
  • flushing
  • headache
1 - 6 months:
  • seborrhoeic keratosis
  • acute myocardial infarction
  • asthma
  • nasal disorder
  • ventricular fibrillation
  • vertigo positional
  • abdominal pain
  • dizziness
  • cardiac arrest
  • drug exposure during pregnancy
6 - 12 months:
  • erythema multiforme
  • pulmonary embolism
  • anxiety
  • cognitive deterioration
  • confusion
  • drug exposure during pregnancy
  • injury
  • insomnia
  • pain
  • pregnancy
1 - 2 years:
  • hyperglycaemia
  • nausea
  • type 2 diabetes mellitus
  • vomiting
  • blood creatinine increased
  • blood potassium decreased
  • brain injury
  • cardiac arrest
  • delirium
  • dementia
2 - 5 years:
  • cardiac failure congestive
  • coronary artery disease
  • ischaemic cardiomyopathy
  • osteoporosis
  • renal failure chronic
  • rib fracture
  • type 1 diabetes mellitus
  • type 2 diabetes mellitus
  • upper limb fracture
  • arteriosclerosis coronary artery
5 - 10 years:
  • hippus
  • suicidal ideation
  • dystonia
  • paraesthesia
  • weakness
  • platelet count
  • chest pain
10+ years:
  • paraesthesia
  • weakness
  • painful respiration
  • urinary frequency
  • urination - bed wetting
not specified:
  • pain
  • dyspnoea
  • fall
  • anxiety
  • dizziness
  • fatigue
  • diarrhoea
  • nausea
  • chest pain
  • back pain

Most common drug interactions by gender *:

female:
  • pain
  • anxiety
  • fall
  • back pain
  • dyspnoea
  • diarrhoea
  • dizziness
  • fatigue
  • nausea
  • injury
male:
  • chest pain
  • depression
  • dizziness
  • dyspnoea
  • hypoaesthesia
  • fatigue
  • hypercholesterolaemia
  • arthralgia
  • myalgia
  • cough

Most common drug interactions by age *:

0-1:
  • blood glucose increased
  • blood potassium decreased
  • delirium
  • dementia
  • diabetic hyperosmolar coma
  • electrolyte imbalance
  • encephalopathy
  • hyperglycaemia
  • hyperlipidaemia
  • hypomagnesaemia
2-9:
  • dyspnoea
  • malaise
  • vomiting
  • cough
  • scar
  • arthropathy
  • dizziness
  • fall
  • fatigue
  • osteoarthritis
10-19:
  • nausea
  • drug ineffective
  • grand mal convulsion
  • fatigue
  • prescribed overdose
  • anaphylactic reaction
  • cough
  • depression
  • abdominal distension
  • abdominal pain
20-29:
  • pruritus
  • urticaria
  • pain
  • anaemia
  • dry mouth
  • dyspnoea
  • fall
  • injury
  • nausea
  • throat tightness
30-39:
  • anxiety
  • pain
  • chest pain
  • dyspnoea
  • injury
  • nausea
  • dizziness
  • deep vein thrombosis
  • pain in extremity
  • pulmonary embolism
40-49:
  • abdominal pain
  • dyspnoea
  • chest pain
  • nausea
  • depression
  • back pain
  • fall
  • headache
  • pneumonia
  • pyrexia
50-59:
  • chest pain
  • dizziness
  • headache
  • nausea
  • fall
  • pain
  • diarrhoea
  • fatigue
  • arthralgia
  • vomiting
60+:
  • bone disorder
  • anxiety
  • fall
  • diarrhoea
  • dyspnoea
  • pain
  • myalgia
  • cough
  • fatigue
  • arthralgia

* Approximation only. Some reports may have incomplete information.

How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.

Do you take Allegra and Zantac?

Can you answer these questions?

More questions for: Allegra, Zantac

You may be interested in these reviews

More reviews for: Allegra, Zantac

On eHealthMe, Allegra (fexofenadine hydrochloride) is often used to treat hypersensitivity. Zantac (ranitidine hydrochloride) is often used to treat indigestion. Find out below the conditions the drugs are used for and how effective they are.

What is the drug used for and how effecitve is it:


NOTE: The study is based on active ingredients and brand name. Other drugs that have the same active ingredients (e.g. generic drugs) are NOT considered.

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

You may report adverse side effects to the FDA at http://www.fda.gov/medwatch/ or 1-800-FDA-1088 (1-800-332-1088).

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.